By Karin Rives For the second time in just four months, the U.S. Department of Justice has settled an off-label marketing case with a major drug maker that directly benefits 340B providers and state Medicaid agencies. The $1.43 billion deal with Eli Lilly – the largest sum paid by a defendant in Justice Department history – signals that safety-net providers are firmly on … [Read more...]
The Waiting Game Continues for Children’s Hospitals
Children’s hospitals have been left out in the cold for nearly three years. When will the feds implement legislation that gave them 340B status?By Victoria Aufiero Nearly three years have passed since Congress approved legislation adding children’s hospitals to the 340B drug discount program. To this day, however, the Health Resources and Services Administration (HRSA) has yet to publish final guidelines allowing such hospitals to take advantage of the program. Children’s hospitals are growing increasingly impatient … [Read more...]